-
-
-
ISO 9001:2015 CERTIFIED
ISO 9001:2015 CERTIFIED
Regorafenib is a multi-kinase inhibitor used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. It works by inhibiting angiogenic, stromal, and oncogenic kinases, reducing tumor growth. Regorafenib API is produced under GMP standards and is suitable for oral solid dosage formulations, including tablets.
Regorafenib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 4 (Page 1 of 1)
CAT No.: AC0341
CAS No.: 835621-11-9
Category: Metabolites
Parent API: Regorafenib
Mol. Formula:
Mol. Wt.:
CAT No.: AC0340
CAS No.: 1255386-16-3
Category: Deuterated Standards
Parent API: Regorafenib
Mol. Formula:
Mol. Wt.:
CAT No.: AS01324
CAS No.: 62476-58-8
Category: Impurities
Parent API: Regorafenib
Mol. Formula: C10H20O
Mol. Wt.: 195.57
CAT No.: AC0769
CAS No.: 755037-03-7
Category: Working Standards
Parent API: Regorafenib
Mol. Formula:
Mol. Wt.:
